EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aeromonas veronii biotype sobria serine protease activates aerolysin and cleaves EpCAM to breach the epithelial barrier

Hidetomo Kobayashi iD, Soshi Seike iD, Eizo Takahashi, Keinosuke Okamoto, Hiroyasu Yamanaka iD

Journal of Bacteriology · 20.08.2026 · 208 (8)

DOI: 10.1128/jb.00141-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bacteriology, erschienen am 20.08.2026. Verfasst von Hidetomo Kobayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Microbiological Science, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima, Japan. Hauptthemen laut MEDLINE: Bacterial Toxins, Serine Proteases, Pore Forming Cytotoxic Proteins, Epithelial Cells. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Hiroshima International University Special Research Grant Program for Research Projects Pursuing Novel Developments.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections by Aeromonas can rapidly progress from mucosal colonization to invasive disease, but how these bacteria efficiently breach epithelial barriers is unclear. Here, we define a coordinated two-component virulence strategy in Aeromonas veronii biotype sobria ( A. veronii sobria) involving a secreted serine protease (ASP) and aerolysin. In polarized T84 monolayers, wild-type infection caused rapid transepithelial electrical resistance (TEER) loss and degradation of junctional/adhesion proteins. An ASP-deficient strain exhibited delayed barrier collapse with reduced cleavage of ZO-1/2/3 and EpCAM, and purified ASP restored these effects, indicating ASP is required but alone insufficient for full disruption. A transposon screen identified aerolysin and secretion-related genes as key contributors to junctional damage. Mechanistically, ASP directly converted recombinant pro-aerolysin into a hemolytically active toxin in vitro , linking protease activity to toxin maturation. Functionally, ASP and aerolysin synergized to promote bacterial translocation across epithelial monolayers with marked sequence dependence; pro-aerolysin pretreatment enhanced ASP-mediated degradation of ZO proteins, claudin-7, and EpCAM. ASP further cleaved EpCAM at multiple extracellular sites, compromising adhesion and junctional homeostasis. Together, these findings establish an ASP–aerolysin pathway that couples toxin activation with junctional proteolysis to drive structural epithelial breaches. IMPORTANCE Aeromonas infections can rapidly progress from intestinal colonization to invasive disease, yet the molecular steps enabling epithelial breach are unclear. We show that Aeromonas veronii sobria uses a coordinated two-factor pathway in which Aeromonas serine protease (ASP) both activates the pore-forming toxin aerolysin and directly cleaves key junctional/adhesion proteins, including ZO-1/2/3 and EpCAM. Aerolysin primes cells for enhanced ASP-mediated proteolysis in an order-dependent manner, converting TEER loss into a physical barrier rupture that permits massive bacterial translocation. Targeting ASP–aerolysin cooperation may provide a rational anti-virulence strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial ToxinsSerine ProteasesPore Forming Cytotoxic ProteinsEpithelial CellsEpithelial Cell Adhesion MoleculeAeromonas veroniiHumansCell LineIntestinal Barrier FunctionVirulenceAeromonas

Stichwörter der Autor:innen

Aeromonas serine protease (ASP)Aeromonas veronii biotype sobriaEpCAMaerolysinclaudin-7epithelial barriertight junctiontransepithelial electrical resistance (TEER)zonula occludens

Substanzen

aerolysinBacterial ToxinsSerine ProteasesPore Forming Cytotoxic ProteinsEpithelial Cell Adhesion Molecule

Autor:innen und Institutionen

  • Laboratory of Molecular Microbiological Science, Faculty of Pharmaceutical Sciences, Hiroshima International University, Kure, Hiroshima, Japan.
  • Laboratory of Medical Microbiology, Department of Health Pharmacy, Yokohama University of Pharmacy, Yokohama, Kanagawa, Japan.
  • Collaborative Research Center of Okayama University for Infectious Diseases in India, National Institute of Cholera Enteric Diseases, Kolkata, India.

ORCID-Profile: Hidetomo Kobayashi, Soshi Seike, Hiroyasu Yamanaka

Förderung

  • Japan Society for the Promotion of Science
  • Hiroshima International University Special Research Grant Program for Research Projects Pursuing Novel Developments

Zitieren

APA

Kobayashi, H., Seike, S., Takahashi, E., Okamoto, K., & Yamanaka, H. (2026). Aeromonas veronii biotype sobria serine protease activates aerolysin and cleaves EpCAM to breach the epithelial barrier. Journal of Bacteriology, 208(8). https://doi.org/10.1128/jb.00141-26

Vancouver

Kobayashi H, Seike S, Takahashi E, Okamoto K, Yamanaka H. Aeromonas veronii biotype sobria serine protease activates aerolysin and cleaves EpCAM to breach the epithelial barrier. Journal of Bacteriology. 2026;208(8). doi:10.1128/jb.00141-26

BibTeX
@article{Kobayashi2026,
  author = {Kobayashi, Hidetomo and Seike, Soshi and Takahashi, Eizo and Okamoto, Keinosuke and Yamanaka, Hiroyasu},
  title = {Aeromonas veronii biotype sobria serine protease activates aerolysin and cleaves EpCAM to breach the epithelial barrier},
  journal = {Journal of Bacteriology},
  year = {2026},
  volume = {208},
  number = {8},
  doi = {10.1128/jb.00141-26}
}
Kostenlos starten →